ÃâÒßѧÊÔÌâ
y1T(R# Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
ciiI{T[Z 1. Fas(CD95)/FasL
5E"^>z 2. common chain of cytokine receptor
g}W|q"l?i 3 . TCR/CD3 complex
(_<,Oj#*S 4. negaive selection of thymocytes
a!-J=\>9 5. artificial active immune
**kix 6. anti-idiotypic
FKz5,PeL 7. IgSF
<F;+A{M) 8. Integrin
7pciB}$2 9. chemokine
0V21_".S 10. B7/CD28
Bf;_~1+vLG ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£©
u4w!SD 1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£
S#v3%)R 2. ±È½ÏCTLºÍNKɱÉË°Ðϸ°ûʱʶ±ðºÍɱÉË»úÖƵÄÌص㡣
|\?u-O3 3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆʵÑé·½°¸¿Ë¡´Ë»ùÒò¡£
kaB4[u 5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½
'&B4Ccn<V FX|&o>S(8 1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£
<Nqbp µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ
Y$\|rD^f Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
c>{QTI:] 1. B7/CD28
2M'dTXz 2. Th1 subset
*wj5( B<y 3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£©
z]+L=+,, 4. antibody affinity maturation
Ec3tfcNhR 5. AP-1
9Pe$}N 6. single chain variable fragment£¨ScFv£©
[K\b"^=< 7. NK cell receptor
T-6<qh 8. Zinkernagel-Doherty phenomenon
0FI
|7 9. Ig fold
PBCGC^0{ 10. CD40/CD40L
SnQT1U% ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£©
YnU)f@b# 1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØϵ¡£
CCe>*tdf 2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿
BB(6[V"SV 3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹Øϵ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿
D\-\U
E/ Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩
CL4N/[UM 1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁÜ°Íϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£
*1<kYrB 2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£
Gw$ 5<%sB 3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æרҵ£©¡£
)
B0%"0?`8 Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
/0XMQy £¨ÃâÒßѧרҵºÍרҵ»ù´¡£©
()l3X.t,$ Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£©
ji1vLu4|t 1.Co-stimulators (or co-stimulating molecules)
9D
Np 2.NK-kB
KRC"3Qt
3.Immunoglobulin superfamily
R/ZScOW[ 4.antigen-presenting cell (APC)
6_bL<:xtY 5.death domain
CC`_e^~y=F 6.CCR and CXCR
$3g{9)} 7.Lectin (or mitogen)
}Ze*/p- 8.Clusters of differentiation, CD)
c
_D(%Vf5 9.B7 family
aLGq<6Ja 10.Cytotoxic T lymphocyte, CTL)
{4G/
HW28 11.IL-15 and IL-15 receptor (IL-15R)
jfY7ich 12.MHC restriction
Qw}1q!89 13.Affinity-chromatography
!B}9gT 14.Cyctosprin A, CsA
yQD>7%x 15.Antibody-dependent cell-mediated cytotoxicity, ADCC)
MVsFi]- ¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£©
y(p_Un
m 1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿
"^n,(l*4x 2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØϵ¡£
7~mhWPzMwB 3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌص㡣
sI!H=bp-8 Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£©
3c=kYcj ÃâÒßѧרҵ£º
05`"U#`: 1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£
l?U=s7s0? Ïû»¯ÄÚ¿Æ£º
[8i)/5D4 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£
|1~n<=`Z ѪҺ²¡Ñ§×¨Òµ£º
qUkMNo3 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎΪÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿
FvxM Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
_F;v3|`D@< (רҵ»ù´¡: ÃâÒßѧ)
,t
wx4r^ Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö)
Fz%;_%j 1. ADCC(antibody dependent cell-mediated cytotoxicity)
b|d-vnYE 2. »·æß¾úËØ(cyclosporin)
<W"W13*j! 3. KIR(killer cell inhibitory receptor)
hJ}i+[~be 4. HLDA(human leucocyte differentiation antigen)
z~
cW, 5. Interleukin 18(IL-18)
'u7-Qetj 6. ÕûºÏËØ(integrin)
-Uwxmy + 7. Fas/FasL
-b(DPte 8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå)
HeRi67 9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM)
*VZ|Idp 10. Th1/Th2
$F2Uv\7= 11. »ùÒòÒßÃç(DNAÒßÃç)
iVXt@[ 12. chemokines and chemokine receptor
o|kykxcq 13. ÃâÒßÄÍÊÜ
}e?H(nZS7h 14. ¹²´Ì¼¤·Ö×Ó
ZSC*{dD$E 15. ËÀÍö½á¹¹Óò(death domain)
HZyA\FS ¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö)
Z}J5sifr 1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉË°Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬?
4Z"}W!A 2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»Æƶø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óá£
=RQF::[h £¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î
fZG Y'o&5 £¨2£©1977Ä꣺·ÅÉäÃâÒß·¨
R6+)&:Ab{R £¨3£©1984Ä꣺ÁÜ°Íϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå
gq7tSkH@ £¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹
:GXF=Df 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄЩÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£
u "[f\l Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ)
i9; ÎÊ´ðÌâ(ÿÌâ25·Ö)
x'GB#svi 1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£
T8XrmR&?PX 2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿
=&}@GsXdo 3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆһϵͳʵÑé,¼ÓÒÔ֤ʵ¡£
{q-&!l| 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃÇ°¾°¡£